Incentives intended to stimulate the development of more treatments for rare diseases are being exploited to boost the profits of pharmaceutical companies, new research led by Bangor University shows.
Oct 21, 2016
3
94
With an aging Baby Boomer population and increasing numbers of childless and unmarried seniors, nearly one-quarter of Americans over age 65 are currently or at risk to become "elder orphans," a vulnerable group requiring ...
May 15, 2015
1
99
Pirfenidone inhibits the development of inflammation and scarring (fibrosis) in pulmonary tissue and has been approved for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) since the beginning of 2011. ...
Jan 3, 2012
0
0
From reading and hearing news accounts, the general public has a vague impression that some things are amiss with the pharmaceutical industry—one word: Epipens. But few might consider it an industry in a state of collapse.
Jan 12, 2017
0
49
Rwandan children who lived through the horrors of the 1994 genocide may suffer from psychological trauma that makes them more vulnerable to health problems, such as HIV infection. But a medical school study shows that with ...
Aug 8, 2011
0
0
Pharmaceutical companies developing Orphan Drugs are increasingly partnering with direct-to-consumer (DTC) genetic testing firms to identify individuals with rare diseases, in a trend that is raising concerns related to privacy, ...
Sep 27, 2017
0
0
How can insurers justify spending hundreds of thousands of dollars per patient per year on "orphan drugs" – extremely expensive medications for rare conditions that are mostly chronic and life-threatening -- when this ...
Feb 7, 2012
0
0
UNSW research shows Australia has much to learn from China's high quality, sustainable foster care system.
Jan 22, 2014
0
0
Drugs used to treat rare conditions are earning pharmaceutical companies almost as much as those marketed to the general public, according to a researcher at West Virginia University. Sean Tu, a College of Law professor found ...
Jun 12, 2023
0
71
Scientists have long known that cancer can hijack a cell's existing regulatory circuitry and transform healthy cells into deadly malignancies. But a new discovery from UC San Francisco demonstrates that cancer is more than ...
Nov 8, 2018
0
53
